AU3489789A - Tryptophan and anti-tussive drug in oral composition - Google Patents

Tryptophan and anti-tussive drug in oral composition

Info

Publication number
AU3489789A
AU3489789A AU34897/89A AU3489789A AU3489789A AU 3489789 A AU3489789 A AU 3489789A AU 34897/89 A AU34897/89 A AU 34897/89A AU 3489789 A AU3489789 A AU 3489789A AU 3489789 A AU3489789 A AU 3489789A
Authority
AU
Australia
Prior art keywords
tryptophan
oral composition
tussive drug
tussive
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34897/89A
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of AU3489789A publication Critical patent/AU3489789A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
AU34897/89A 1988-05-18 1989-05-17 Tryptophan and anti-tussive drug in oral composition Abandoned AU3489789A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19557888A 1988-05-18 1988-05-18
US195578 1988-05-18

Publications (1)

Publication Number Publication Date
AU3489789A true AU3489789A (en) 1989-11-23

Family

ID=22721947

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34897/89A Abandoned AU3489789A (en) 1988-05-18 1989-05-17 Tryptophan and anti-tussive drug in oral composition

Country Status (5)

Country Link
JP (1) JPH0262823A (en)
KR (1) KR900017584A (en)
AU (1) AU3489789A (en)
NZ (1) NZ229164A (en)
PH (1) PH26900A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0395115A (en) * 1989-06-15 1991-04-19 Taisho Pharmaceut Co Ltd Antitussive
KR100610252B1 (en) * 2004-07-01 2006-08-10 주식회사 엘지생활건강 Iontophoresis device

Also Published As

Publication number Publication date
PH26900A (en) 1992-12-03
NZ229164A (en) 1992-02-25
JPH0262823A (en) 1990-03-02
KR900017584A (en) 1990-12-19

Similar Documents

Publication Publication Date Title
ZA942804B (en) Oral drug delivery compositions and methods
AU628817B2 (en) Tartar inhibiting oral composition and method
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
NZ231445A (en) Quinuclidine derivatives and pharmaceutical compositions
AU1429488A (en) Human interleukin-3 and muteins thereof
IL90158A0 (en) Perfluoropolyether derivatives and their preparation
AU5650890A (en) Indole derivatives and medicine
AU4466889A (en) Solfonium salts and use and preparation thereof
AU3480989A (en) Oral preparations
NZ228098A (en) Quinoline derivatives and pharmaceutical compositions
IL92138A0 (en) Pharmaceutical compositions containing piroxicam and their preparation
AU8316587A (en) Pharmaceutical compositions and their use
EP0346882A3 (en) Hydroxyalkylcysteine derivative and expectorant containing the same
AU2557892A (en) New beta -carbolin derivatives, their preparation and their use in drugs
AU3502789A (en) Composition and use
GR900300044T1 (en) Use of monosubstitute selenium compounds in the preparation of a pharmaceutical, pharmaceutical and preparation thereof
GB8808758D0 (en) Nutritional and medicinal compositions
GB2221464B (en) Oxaza heterocycles and their use in pharmaceutical compositions
AU2798689A (en) Oral dosage units for pharmaceuticals and their use and preparation
AU3489789A (en) Tryptophan and anti-tussive drug in oral composition
AU3752189A (en) Pharmaceutical compositions and use thereof in treating inflammation
AU1450788A (en) Thiophene-2-carbox-amide derivatives and their pharmaceutical use
AU4305589A (en) Dental prostheses and connectors for use in such prostheses
AU4098289A (en) Improvements in condoms
AU3315289A (en) Benzothiazepin-4-one derivatives, their preparation and their application in therapy